Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Neurovirol ; 23(3): 422-429, 2017 06.
Article in English | MEDLINE | ID: mdl-28101804

ABSTRACT

Our aim was to examine the clinical relevance of white matter hyperintensities (WMH) in HIV. We used an automated approach to quantify WMH volume in HIV seropositive (HIV+; n = 65) and HIV seronegative (HIV-; n = 29) adults over age 60. We compared WMH volumes between HIV+ and HIV- groups in cross-sectional and multiple time-point analyses. We also assessed correlations between WMH volumes and cardiovascular, HIV severity, cognitive scores, and diffusion tensor imaging variables. Serostatus groups did not differ in WMH volume, but HIV+ participants had less cerebral white matter (mean: 470.95 [43.24] vs. 497.63 [49.42] mL, p = 0.010). The distribution of WMH volume was skewed in HIV+ with a high proportion (23%) falling above the 95th percentile of WMH volume defined by the HIV- group. Serostatus groups had similar amount of WMH volume growth over time. Total WMH volume directly correlated with measures of hypertension and inversely correlated with measures of global cognition, particularly in executive functioning, and psychomotor speed. Greater WMH volume was associated with poorer brain integrity measured from diffusion tensor imaging (DTI) in the corpus callosum and sagittal stratum. In this group of HIV+ individuals over 60, WMH burden was associated with cardiovascular risk and both worse diffusion MRI and cognition. The median total burden did not differ by serostatus; however, a subset of HIV+ individuals had high WMH burden.


Subject(s)
Cerebral Cortex/pathology , Corpus Callosum/pathology , HIV Infections/pathology , Hypertension/pathology , RNA, Viral/blood , White Matter/pathology , Aged , Aged, 80 and over , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/virology , Cognition/physiology , Corpus Callosum/diagnostic imaging , Corpus Callosum/virology , Cross-Sectional Studies , Diffusion Tensor Imaging , Executive Function/physiology , Female , HIV Infections/diagnostic imaging , HIV Infections/virology , HIV-1/pathogenicity , HIV-1/physiology , Humans , Hypertension/diagnostic imaging , Hypertension/virology , Male , Middle Aged , Neuropsychological Tests , Severity of Illness Index , White Matter/diagnostic imaging , White Matter/virology
2.
AIDS Care ; 29(9): 1178-1185, 2017 09.
Article in English | MEDLINE | ID: mdl-28127989

ABSTRACT

Psychiatric comorbidities are common in people living with HIV (PLWH) and adversely affect life satisfaction, treatment adherence and disease progression. There are few data to inform the burden of psychiatric symptoms in older PLWH, a rapidly growing demographic in the U.S. We performed a cross-sectional analysis to understand the degree to which symptom burden was associated with cognitive disorders in PLWH over age 60. Participants completed a standardized neuropsychological battery and were assigned cognitive diagnoses using Frascati criteria. We captured psychiatric symptom burden using the Geriatric Depression Scale (GDS) and proxy-informed Neuropsychiatric Inventory-Questionnaire (NPI-Q). Those diagnosed with HIV-associated neurocognitive disorders (HAND, n = 39) were similar to those without HAND (n = 35) by age (median = 67 years for each group, p = 0.696), education (mean = 16 years vs. 17 years, p = 0.096), CD4+ T-lymphocyte counts (mean = 520 vs. 579, p = 0.240), duration of HIV (median = 21 years for each group, p = 0.911) and sex (92% male in HAND vs. 97% in non-HAND, p = 0.617). Our findings showed similarities in HAND and non-HAND groups on both NPI-Q (items and clusters) and GDS scores. However, there was a greater overall symptom burden in HIV compared to healthy elder controls (n = 236, p < 0.05), with more frequent agitation, depression, anxiety, apathy, irritability and nighttime behavior disturbances (p < 0.05). Our findings demonstrate no differences in psychiatric comorbidity by HAND status in older HIV participants; but confirm a substantial neurobehavioral burden in this older HIV-infected population.


Subject(s)
Aged/psychology , Cognitive Dysfunction/psychology , Depression/psychology , HIV Infections/psychology , Quality of Life , Aged, 80 and over , Anxiety/diagnosis , Anxiety/epidemiology , Anxiety/psychology , Cognition Disorders/epidemiology , Cognition Disorders/psychology , Cognitive Dysfunction/diagnosis , Cognitive Dysfunction/epidemiology , Cohort Studies , Comorbidity , Cross-Sectional Studies , Depression/diagnosis , Depression/epidemiology , Depressive Disorder/epidemiology , Depressive Disorder/psychology , Female , HIV Infections/epidemiology , Humans , Male , Medication Adherence , Middle Aged , Neuropsychological Tests
3.
Hum Brain Mapp ; 37(12): 4523-4538, 2016 12.
Article in English | MEDLINE | ID: mdl-27489003

ABSTRACT

HIV-Associated Neurocognitive Disorder (HAND) is the most common constellation of cognitive dysfunctions in chronic HIV infected patients age 60 or older in the U.S. Only few published methods assist in distinguishing HAND from other forms of age-associated cognitive decline, such as Mild Cognitive Impairment (MCI). In this report, a data-driven, nonparameteric model to identify morphometric patterns separating HAND from MCI due to non-HIV conditions in this older age group was proposed. This model enhanced the potential for group separation by combining a smaller, longitudinal data set containing HAND samples with a larger, public data set including MCI cases. Using cross-validation, a linear model on healthy controls to harmonize the volumetric scores extracted from MRIs for demographic and acquisition differences between the two independent, disease-specific data sets was trained. Next, patterns distinguishing HAND from MCI via a group sparsity constrained logistic classifier were identified. Unlike existing approaches, our classifier directly solved the underlying minimization problem by decoupling the minimization of the logistic regression function from enforcing the group sparsity constraint. The extracted patterns consisted of eight regions that distinguished HAND from MCI on a significant level while being indifferent to differences in demographics and acquisition between the two sets. Individually selecting regions through conventional morphometric group analysis resulted in a larger number of regions that were less accurate. In conclusion, simultaneously analyzing all brain regions and time points for disease specific patterns contributed to distinguishing with high accuracy HAND-related impairment from cognitive impairment found in the HIV uninfected, MCI cohort. Hum Brain Mapp 37:4523-4538, 2016. © 2016 Wiley Periodicals, Inc.


Subject(s)
AIDS Dementia Complex/diagnostic imaging , Cognitive Dysfunction/diagnostic imaging , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging , Neurodegenerative Diseases/diagnostic imaging , AIDS Dementia Complex/complications , Aged , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Imaging, Three-Dimensional , Linear Models , Logistic Models , Longitudinal Studies , Male , Middle Aged , Neurodegenerative Diseases/etiology , Organ Size , Pattern Recognition, Automated/methods
4.
J Neurovirol ; 22(1): 80-7, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26265137

ABSTRACT

Individuals infected with HIV are living longer due to effective treatment with combination antiretroviral therapy (cART). Despite these advances, HIV-associated neurocognitive disorders (HAND) remain prevalent. In this study, we analyzed resting state functional connectivity (rs-fc) data from HIV-infected and matched HIV-uninfected adults aged 60 years and older to determine associations between HIV status, neuropsychological performance, and clinical variables. HIV-infected participants with detectable plasma HIV RNA exhibited decreased rs-fc within the salience (SAL) network compared to HIV-infected participants with suppressed plasma HIV RNA. We did not identify differences in rs-fc within HIV-infected individuals by HAND status. Our analysis identifies focal deficits in the SAL network that may be mitigated with suppression of plasma virus. However, these findings suggest that rs-fc may not be sensitive as a marker of HAND among individuals with suppressed plasma viral loads.


Subject(s)
Anti-HIV Agents/therapeutic use , Brain/physiopathology , Cognition Disorders/physiopathology , HIV Infections/physiopathology , Nerve Net/physiopathology , RNA, Viral/blood , Aged , Antiretroviral Therapy, Highly Active , Brain/virology , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/pathology , CD4-Positive T-Lymphocytes/virology , Case-Control Studies , Cognition Disorders/complications , Cognition Disorders/drug therapy , Cognition Disorders/virology , Female , Functional Neuroimaging , HIV Infections/complications , HIV Infections/drug therapy , HIV Infections/virology , Humans , Male , Middle Aged , Nerve Net/drug effects , Nerve Net/virology , Neuropsychological Tests , RNA, Viral/antagonists & inhibitors , Viral Load/drug effects
5.
Neuroimage Clin ; 9: 564-73, 2015.
Article in English | MEDLINE | ID: mdl-26640768

ABSTRACT

Over 50% of HIV + individuals exhibit neurocognitive impairment and subcortical atrophy, but the profile of brain abnormalities associated with HIV is still poorly understood. Using surface-based shape analyses, we mapped the 3D profile of subcortical morphometry in 63 elderly HIV + participants and 31 uninfected controls. The thalamus, caudate, putamen, pallidum, hippocampus, amygdala, brainstem, accumbens, callosum and ventricles were segmented from high-resolution MRIs. To investigate shape-based morphometry, we analyzed the Jacobian determinant (JD) and radial distances (RD) defined on each region's surfaces. We also investigated effects of nadir CD4 + T-cell counts, viral load, time since diagnosis (TSD) and cognition on subcortical morphology. Lastly, we explored whether HIV + participants were distinguishable from unaffected controls in a machine learning context. All shape and volume features were included in a random forest (RF) model. The model was validated with 2-fold cross-validation. Volumes of HIV + participants' bilateral thalamus, left pallidum, left putamen and callosum were significantly reduced while ventricular spaces were enlarged. Significant shape variation was associated with HIV status, TSD and the Wechsler adult intelligence scale. HIV + people had diffuse atrophy, particularly in the caudate, putamen, hippocampus and thalamus. Unexpectedly, extended TSD was associated with increased thickness of the anterior right pallidum. In the classification of HIV + participants vs. controls, our RF model attained an area under the curve of 72%.


Subject(s)
Brain Mapping , Brain/pathology , HIV Infections/pathology , Aged , Brain/virology , CD4-Positive T-Lymphocytes/pathology , Case-Control Studies , Cognition Disorders/etiology , Cohort Studies , Female , HIV Infections/complications , Humans , Image Processing, Computer-Assisted , Linear Models , Magnetic Resonance Imaging , Male , Middle Aged , ROC Curve
6.
Proc IEEE Int Symp Biomed Imaging ; 2015: 971-975, 2015 Apr.
Article in English | MEDLINE | ID: mdl-26413207

ABSTRACT

Over 50% of HIV+ individuals exhibit neurocognitive impairment and subcortical atrophy, but the pattern of brain abnormalities associated with HIV is still poorly understood. Using parametric surface-based shape analyses, we mapped the 3D profile of subcortical morphometry in 63 HIV+ participants and 31 uninfected controls. The thalamus, corpus striatum, hippocampus, amygdala, brainstem, callosum and ventricles were segmented from brain MRIs. To investigate subcortical shape, we analyzed the Jacobian determinant (JD) and radial distances (RD) for structure surfaces. We also investigated effects of nadir CD4+ T-cell counts, viral load, and illness duration on subcortical morphology. Our results characterize subcortical morphometry in older HIV+ people, where participants showed significant volumetric enlargements in the thalamus, left pallidum and the ventricles while showing a reduction in the callosum. Further, RD maps revealed atrophy of the left thalamus and expansion of the brainstem in HIV. RD and JD maps of the right pallidum identified tissue expansion associated with illness duration while the left pallidum showed anterior atrophy and posterior expansion associated with viral load.

7.
Proc SPIE Int Soc Opt Eng ; 94172015 Mar 17.
Article in English | MEDLINE | ID: mdl-25844123

ABSTRACT

Over 50% of HIV+ individuals show significant impairment in psychomotor functioning, processing speed, working memory and attention [1, 2]. Patients receiving combination antiretroviral therapy may still have subcortical atrophy, but the profile of HIV-associated brain changes is poorly understood. With parametric surface-based shape analyses, we mapped the 3D profile of subcortical morphometry in 63 elderly HIV+ subjects (4 female; age=65.35 ± 2.21) and 31 uninfected elderly controls (2 female; age=64.68 ± 4.57) scanned with MRI as part of a San Francisco Bay Area study of elderly people with HIV. We also investigated whether morphometry was associated with nadir CD4+ (T-cell) counts, viral load and illness duration among HIV+ participants. FreeSurfer was used to segment the thalamus, caudate, putamen, pallidum, hippocampus, amygdala, accumbens, brainstem, callosum and ventricles from brain MRI scans. To study subcortical shape, we analyzed: (1) the Jacobian determinant (JD) indexed over structures' surface coordinates and (2) radial distances (RD) of structure surfaces from a medial curve. A JD less than 1 reflects regional tissue atrophy and greater than 1 reflects expansion. The volumes of several subcortical regions were found to be associated with HIV status. No regional volumes showed detectable associations with CD4 counts, viral load or illness duration. The shapes of numerous subcortical regions were significantly linked to HIV status, detectability of viral RNA and illness duration. Our results show subcortical brain differences in HIV+ subjects in both shape and volumetric domains.

8.
J Acquir Immune Defic Syndr ; 67(1): 67-70, 2014 Sep 01.
Article in English | MEDLINE | ID: mdl-24872137

ABSTRACT

Progress in HIV treatments has led to HIV-infected patients living into their 60s and older. Because HIV-associated neurocognitive disorder (HAND) in older age is associated with more executive dysfunction, cognitive screening instruments tapping this domain may be optimal. We examined the Montreal Cognitive Assessment to identify HAND in 67 HIV-infected patients older than 60 years, of which 40% were diagnosed with HAND. Receiver operating characteristic curve identified an optimal cutpoint of ≤ 25 for HAND with a sensitivity of 72% and specificity of 67%. We conclude that the Montreal Cognitive Assessment has only moderate performance characteristics for cognitive screening of HIV-infected elders.


Subject(s)
Cognition Disorders/virology , HIV Infections/psychology , HIV , Age Factors , Aged , Area Under Curve , Female , Humans , Male , Middle Aged , Neuropsychological Tests , ROC Curve , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...